While at the American Health Law Association's 2026 Health Care Transactions Conference in Nashville, the Levin Associates team asked several attendees, including Baker Donelson Shareholder Glenn Prives, what they view as the biggest regulatory hurdles in healthcare transactions right now in 2026. Attendees highlighted the rising challenges from proliferating state transaction review laws and heightened fraud and abuse enforcement.